Literature DB >> 12588074

Cytomegalovirus.

Gregory H Taylor1.   

Abstract

Cytomegalovirus (CMV) is a prevalent viral pathogen. The majority of persons with acute CMV will experience an inapparent infection. Primary CMV infection will cause up to 7 percent of cases of mononucleosis syndrome and will manifest symptoms almost indistinguishable from those of Epstein-Barr virus-induced mononucleosis. CMV, or heterophil-negative mononucleosis, is best diagnosed using a positive IgM serology. Complications of acute CMV infection in immunocompetent persons are rare, except in newborns. The virus usually is spread through close personal contact; transmission risk can be reduced by following simple hygienic and handwashing techniques. Severe illness can occur after reactivation of the latent virus in immunosuppressed persons. The retina is the most common site of CMV-induced pathology in persons with human immunodeficiency virus infection. Advances in the treatment of human immunodeficiency virus infection with highly active antiretroviral therapy (HAART) have decreased the incidence of CMV retinitis but have resulted in a new set of ophthalmologic complications induced by restoration of immune competency and the pro-inflammatory response of the patient to CMV. If HAART restores the patient's CD4 cell count to above 100 to 150 per mm3 (100 to 150 x 10(6) per L), it may preclude lifelong treatment for CMV retinitis.

Entities:  

Mesh:

Year:  2003        PMID: 12588074

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  30 in total

1.  Cytomegalovirus, inflammatory bowel disease, and anti-TNFα.

Authors:  Sara T Campos; Francisco A Portela; Luís Tomé
Journal:  Int J Colorectal Dis       Date:  2017-01-13       Impact factor: 2.571

2.  Cytomegalovirus may mimic the presentation of intrahepatic cholestasis and hemolysis, elevated liver enzymes and low platelets in immunosuppressed pregnant women.

Authors:  Gurleen Wander; Francesa Neuberger; Mandish K Dhanjal; Catherine Nelson-Piercy; May Ching Soh
Journal:  Obstet Med       Date:  2016-05-05

3.  Cytomegalovirus Reactivation in Ulcerative Colitis Patients.

Authors:  Minh Nguyen; Kara Bradford; Xiaolan Zhang; David Q Shih
Journal:  Ulcers       Date:  2011-01-01

4.  Small intestinal perforation caused by cytomegalovirus reactivation after subtotal colectomy for ulcerative colitis: report of a case.

Authors:  Hiroyuki Fujikawa; Toshimitsu Araki; Tadanobu Shimura; Yoshiki Okita; Koji Tanaka; Mikihiro Inoue; Mikio Kawamura; Yasuhiro Inoue; Yasuhiko Mohri; Keiichi Uchida; Masato Kusunoki
Journal:  Clin J Gastroenterol       Date:  2013-02-15

5.  Cytomegalovirus ileitis in an immunocompetent elderly adult.

Authors:  Kum Hei Ryu; Sun Young Yi
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

Review 6.  Human inborn errors of immunity to herpes viruses.

Authors:  Emmanuelle Jouanguy; Vivien Béziat; Trine H Mogensen; Jean-Laurent Casanova; Stuart G Tangye; Shen-Ying Zhang
Journal:  Curr Opin Immunol       Date:  2020-01-31       Impact factor: 7.486

Review 7.  Challenges and Clinical Implications of the Diagnosis of Cytomegalovirus Lung Infection in Children.

Authors:  Sonia M Restrepo-Gualteros; Maria J Gutierrez; Milena Villamil-Osorio; Maria A Arroyo; Gustavo Nino
Journal:  Curr Infect Dis Rep       Date:  2019-05-30       Impact factor: 3.725

Review 8.  Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts.

Authors:  Polymnia Galiatsatos; Ian Shrier; Esther Lamoureux; Andrew Szilagyi
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

9.  The role of decay accelerating factor in the immunopathogenesis of cytomegalovirus infection.

Authors:  M Bani-Ahmad; I S El-Amouri; C M Ko; F Lin; Y Tang-Feldman; O R Oakley
Journal:  Clin Exp Immunol       Date:  2010-12-16       Impact factor: 4.330

10.  Coinfection with EBV/CMV and other respiratory agents in children with suspected infectious mononucleosis.

Authors:  Xia Wang; Kun Yang; Cong Wei; Yuan Huang; Dongchi Zhao
Journal:  Virol J       Date:  2010-09-21       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.